Zydus Lifesciences is set to enter the digital healthcare space with the planned launch of artificial intelligence (AI)-based glucose monitoring devices, marking a strategic expansion into technology driven diabetes management solutions. The upcoming devices are expected to leverage AI algorithms and real-time data analytics to provide
